Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-11-18

AUTHORS

Chul Hee Min, Harald Paganetti, Brian A Winey, Judith Adams, Shannon M MacDonald, Nancy J Tarbell, Torunn I Yock

ABSTRACT

BackgroundTo precisely calculate skin dose and thus to evaluate the relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with proton beams.MethodsThe dosimetry and alopecia outcomes of 12 children with medulloblastoma (ages 4-15 years) comprise the study cohort. Permanent alopecia was assessed and graded after completion of the entire therapy. Skin threshold doses of permanent alopecia were calculated based on the skin dose from the craniospinal irradiation (CSI) plan using the concept of generalized equivalent uniform dose (gEUD) and accounting for chemotherapy intensity. Monte Carlo simulations were employed to accurately assess uncertainties due to beam range prediction and secondary particles.ResultsIncreasing the dose of the CSI field or the dose given by the boost field to the posterior fossa increased total skin dose delivered in that region. It was found that permanent alopecia could be correlated with CSI dose with a threshold of about 21 Gy (relative biological effectiveness, RBE) with high dose chemotherapy and 30 Gy (RBE) with conventional chemotherapy.ConclusionsOur results based on 12 patients provide a relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with protons. The alopecia risk as assessed with gEUD could be predicted based on the treatment plan information. More... »

PAGES

220

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13014-014-0220-8

DOI

http://dx.doi.org/10.1186/s13014-014-0220-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007883566

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25403752


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alopecia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cerebellar Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Craniospinal Irradiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medulloblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Monte Carlo Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proton Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Planning, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Intensity-Modulated", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Relative Biological Effectiveness", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiation Convergence Engineering, Yonsei University, Wonju, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
            "Department of Radiation Convergence Engineering, Yonsei University, Wonju, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Min", 
        "givenName": "Chul Hee", 
        "id": "sg:person.014651513125.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014651513125.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paganetti", 
        "givenName": "Harald", 
        "id": "sg:person.01103024072.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103024072.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Winey", 
        "givenName": "Brian A", 
        "id": "sg:person.01060575552.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575552.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adams", 
        "givenName": "Judith", 
        "id": "sg:person.016700357012.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016700357012.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "MacDonald", 
        "givenName": "Shannon M", 
        "id": "sg:person.01001210123.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001210123.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarbell", 
        "givenName": "Nancy J", 
        "id": "sg:person.01144720071.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144720071.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yock", 
        "givenName": "Torunn I", 
        "id": "sg:person.01264377732.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264377732.13"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2014-11-18", 
    "datePublishedReg": "2014-11-18", 
    "description": "BackgroundTo precisely calculate skin dose and thus to evaluate the relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with proton beams.MethodsThe dosimetry and alopecia outcomes of 12 children with medulloblastoma (ages 4-15 years) comprise the study cohort. Permanent alopecia was assessed and graded after completion of the entire therapy. Skin threshold doses of permanent alopecia were calculated based on the skin dose from the craniospinal irradiation (CSI) plan using the concept of generalized equivalent uniform dose (gEUD) and accounting for chemotherapy intensity. Monte Carlo simulations were employed to accurately assess uncertainties due to beam range prediction and secondary particles.ResultsIncreasing the dose of the CSI field or the dose given by the boost field to the posterior fossa increased total skin dose delivered in that region. It was found that permanent alopecia could be correlated with CSI dose with a threshold of about 21 Gy (relative biological effectiveness, RBE) with high dose chemotherapy and 30 Gy (RBE) with conventional chemotherapy.ConclusionsOur results based on 12 patients provide a relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with protons. The alopecia risk as assessed with gEUD could be predicted based on the treatment plan information.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13014-014-0220-8", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2435408", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "pediatric medulloblastoma patients", 
      "permanent alopecia", 
      "medulloblastoma patients", 
      "skin dose", 
      "high-dose chemotherapy", 
      "total skin dose", 
      "equivalent uniform dose", 
      "CSI dose", 
      "chemotherapy intensity", 
      "dose chemotherapy", 
      "study cohort", 
      "conventional chemotherapy", 
      "posterior fossa", 
      "threshold doses", 
      "alopecia", 
      "patients", 
      "boost field", 
      "dose", 
      "entire therapy", 
      "treatment plan information", 
      "uniform dose", 
      "ConclusionsOur results", 
      "chemotherapy", 
      "irradiation plan", 
      "CSI fields", 
      "therapy", 
      "cohort", 
      "medulloblastoma", 
      "fossa", 
      "doses", 
      "proton radiation", 
      "outcomes", 
      "gEUD", 
      "children", 
      "risk", 
      "plan information", 
      "completion", 
      "evaluation", 
      "relationship", 
      "dosimetry", 
      "threshold", 
      "plan", 
      "results", 
      "information", 
      "radiation", 
      "intensity", 
      "region", 
      "prediction", 
      "concept", 
      "field", 
      "proton beam", 
      "particles", 
      "uncertainty", 
      "Monte Carlo simulations", 
      "Carlo simulations", 
      "protons", 
      "beam", 
      "range prediction", 
      "simulations", 
      "secondary particles"
    ], 
    "name": "Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation", 
    "pagination": "220", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007883566"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13014-014-0220-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25403752"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13014-014-0220-8", 
      "https://app.dimensions.ai/details/publication/pub.1007883566"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_644.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13014-014-0220-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13014-014-0220-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13014-014-0220-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13014-014-0220-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13014-014-0220-8'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      20 PREDICATES      104 URIs      96 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13014-014-0220-8 schema:about N0adfa39a81c74fdba0d68b3c0356b85a
2 N0b9b0d697a014289916abac499d07b35
3 N26ca39d0eee440eb9b569870ba4da8df
4 N34020826688d4151bce64862a85a2393
5 N3a535e7e0ca54f828a14f392bd474a78
6 N3dec395b004047568409bfc376d6d03e
7 N5ea899f73b6544e5913d81935e78bddd
8 N7f9c3d3065454859a2ea6d3ee298cc78
9 N8b2c272b5c5e43509df3bb5bda5267b8
10 N8c6e6f4a451c47f4a619da169a61415a
11 N8e9bf50ae7e54a6c813e67f199ecd177
12 Na2a4011c8cfe4e1f9561e4dec863b675
13 Na2cf5ed59fb94d49a6e4e68b5dfbeb5e
14 Nad2c4d8ee6bb490b83a2f1a1f5ea41e2
15 Nc0db88b2ba5d400b9f53de884974fa51
16 Nc7c79e9e88e14a0da46df4bef1927611
17 Nd21a0e6b390c4977b216d5926227a033
18 Nd5c87a22b3844b4fafbfbc5b758a0d1d
19 Nd92bb67f78e34c419c6a8f68e2a049b1
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author Nc24d3343007a48e3b1f13b105f8c60fb
23 schema:datePublished 2014-11-18
24 schema:datePublishedReg 2014-11-18
25 schema:description BackgroundTo precisely calculate skin dose and thus to evaluate the relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with proton beams.MethodsThe dosimetry and alopecia outcomes of 12 children with medulloblastoma (ages 4-15 years) comprise the study cohort. Permanent alopecia was assessed and graded after completion of the entire therapy. Skin threshold doses of permanent alopecia were calculated based on the skin dose from the craniospinal irradiation (CSI) plan using the concept of generalized equivalent uniform dose (gEUD) and accounting for chemotherapy intensity. Monte Carlo simulations were employed to accurately assess uncertainties due to beam range prediction and secondary particles.ResultsIncreasing the dose of the CSI field or the dose given by the boost field to the posterior fossa increased total skin dose delivered in that region. It was found that permanent alopecia could be correlated with CSI dose with a threshold of about 21 Gy (relative biological effectiveness, RBE) with high dose chemotherapy and 30 Gy (RBE) with conventional chemotherapy.ConclusionsOur results based on 12 patients provide a relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with protons. The alopecia risk as assessed with gEUD could be predicted based on the treatment plan information.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N43b0d5e44cc246d6bf0a42a0cee2c6ac
29 N59c8b20e9bc64c8f8c49ddd9355e020f
30 sg:journal.1036451
31 schema:keywords CSI dose
32 CSI fields
33 Carlo simulations
34 ConclusionsOur results
35 Monte Carlo simulations
36 alopecia
37 beam
38 boost field
39 chemotherapy
40 chemotherapy intensity
41 children
42 cohort
43 completion
44 concept
45 conventional chemotherapy
46 dose
47 dose chemotherapy
48 doses
49 dosimetry
50 entire therapy
51 equivalent uniform dose
52 evaluation
53 field
54 fossa
55 gEUD
56 high-dose chemotherapy
57 information
58 intensity
59 irradiation plan
60 medulloblastoma
61 medulloblastoma patients
62 outcomes
63 particles
64 patients
65 pediatric medulloblastoma patients
66 permanent alopecia
67 plan
68 plan information
69 posterior fossa
70 prediction
71 proton beam
72 proton radiation
73 protons
74 radiation
75 range prediction
76 region
77 relationship
78 results
79 risk
80 secondary particles
81 simulations
82 skin dose
83 study cohort
84 therapy
85 threshold
86 threshold doses
87 total skin dose
88 treatment plan information
89 uncertainty
90 uniform dose
91 schema:name Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation
92 schema:pagination 220
93 schema:productId N202d780cb4af4558987d469709178896
94 Ne055ff35239943c4b14162011bcbb856
95 Neb7d0679179240179f9f48a6eced837a
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007883566
97 https://doi.org/10.1186/s13014-014-0220-8
98 schema:sdDatePublished 2022-11-24T20:59
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Nd0ad026c759149c6bb21d741e9e89051
101 schema:url https://doi.org/10.1186/s13014-014-0220-8
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N02f1d28a0ce64b33816b830cd5dc90aa rdf:first sg:person.01060575552.66
106 rdf:rest Nce3c3756fee74baaa7a22a96aed7c199
107 N0adfa39a81c74fdba0d68b3c0356b85a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Adolescent
109 rdf:type schema:DefinedTerm
110 N0b9b0d697a014289916abac499d07b35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Craniospinal Irradiation
112 rdf:type schema:DefinedTerm
113 N0db1c1bf7de74eb5b7d2118917f687cb rdf:first sg:person.01264377732.13
114 rdf:rest rdf:nil
115 N1585284703f5468e902f6a3c5021c9f6 rdf:first sg:person.01103024072.39
116 rdf:rest N02f1d28a0ce64b33816b830cd5dc90aa
117 N202d780cb4af4558987d469709178896 schema:name pubmed_id
118 schema:value 25403752
119 rdf:type schema:PropertyValue
120 N26ca39d0eee440eb9b569870ba4da8df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 N34020826688d4151bce64862a85a2393 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Male
125 rdf:type schema:DefinedTerm
126 N3a535e7e0ca54f828a14f392bd474a78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cohort Studies
128 rdf:type schema:DefinedTerm
129 N3dec395b004047568409bfc376d6d03e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cerebellar Neoplasms
131 rdf:type schema:DefinedTerm
132 N43b0d5e44cc246d6bf0a42a0cee2c6ac schema:volumeNumber 9
133 rdf:type schema:PublicationVolume
134 N59c8b20e9bc64c8f8c49ddd9355e020f schema:issueNumber 1
135 rdf:type schema:PublicationIssue
136 N5ea899f73b6544e5913d81935e78bddd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Follow-Up Studies
138 rdf:type schema:DefinedTerm
139 N74edb8231e294edba7a16a3c23b70d14 rdf:first sg:person.01144720071.98
140 rdf:rest N0db1c1bf7de74eb5b7d2118917f687cb
141 N7be51290ca8e4fe1837048f2e3354197 rdf:first sg:person.01001210123.43
142 rdf:rest N74edb8231e294edba7a16a3c23b70d14
143 N7f9c3d3065454859a2ea6d3ee298cc78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Radiotherapy Planning, Computer-Assisted
145 rdf:type schema:DefinedTerm
146 N8b2c272b5c5e43509df3bb5bda5267b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Prognosis
148 rdf:type schema:DefinedTerm
149 N8c6e6f4a451c47f4a619da169a61415a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Radiotherapy Dosage
151 rdf:type schema:DefinedTerm
152 N8e9bf50ae7e54a6c813e67f199ecd177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Medulloblastoma
154 rdf:type schema:DefinedTerm
155 Na2a4011c8cfe4e1f9561e4dec863b675 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Alopecia
157 rdf:type schema:DefinedTerm
158 Na2cf5ed59fb94d49a6e4e68b5dfbeb5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Radiotherapy, Intensity-Modulated
160 rdf:type schema:DefinedTerm
161 Nad2c4d8ee6bb490b83a2f1a1f5ea41e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Child, Preschool
163 rdf:type schema:DefinedTerm
164 Nc0db88b2ba5d400b9f53de884974fa51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Female
166 rdf:type schema:DefinedTerm
167 Nc24d3343007a48e3b1f13b105f8c60fb rdf:first sg:person.014651513125.83
168 rdf:rest N1585284703f5468e902f6a3c5021c9f6
169 Nc7c79e9e88e14a0da46df4bef1927611 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Child
171 rdf:type schema:DefinedTerm
172 Nce3c3756fee74baaa7a22a96aed7c199 rdf:first sg:person.016700357012.88
173 rdf:rest N7be51290ca8e4fe1837048f2e3354197
174 Nd0ad026c759149c6bb21d741e9e89051 schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 Nd21a0e6b390c4977b216d5926227a033 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Relative Biological Effectiveness
178 rdf:type schema:DefinedTerm
179 Nd5c87a22b3844b4fafbfbc5b758a0d1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Proton Therapy
181 rdf:type schema:DefinedTerm
182 Nd92bb67f78e34c419c6a8f68e2a049b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Monte Carlo Method
184 rdf:type schema:DefinedTerm
185 Ne055ff35239943c4b14162011bcbb856 schema:name dimensions_id
186 schema:value pub.1007883566
187 rdf:type schema:PropertyValue
188 Neb7d0679179240179f9f48a6eced837a schema:name doi
189 schema:value 10.1186/s13014-014-0220-8
190 rdf:type schema:PropertyValue
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
195 schema:name Oncology and Carcinogenesis
196 rdf:type schema:DefinedTerm
197 sg:grant.2435408 http://pending.schema.org/fundedItem sg:pub.10.1186/s13014-014-0220-8
198 rdf:type schema:MonetaryGrant
199 sg:journal.1036451 schema:issn 1748-717X
200 schema:name Radiation Oncology
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01001210123.43 schema:affiliation grid-institutes:grid.38142.3c
204 schema:familyName MacDonald
205 schema:givenName Shannon M
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001210123.43
207 rdf:type schema:Person
208 sg:person.01060575552.66 schema:affiliation grid-institutes:grid.38142.3c
209 schema:familyName Winey
210 schema:givenName Brian A
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575552.66
212 rdf:type schema:Person
213 sg:person.01103024072.39 schema:affiliation grid-institutes:grid.38142.3c
214 schema:familyName Paganetti
215 schema:givenName Harald
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103024072.39
217 rdf:type schema:Person
218 sg:person.01144720071.98 schema:affiliation grid-institutes:grid.38142.3c
219 schema:familyName Tarbell
220 schema:givenName Nancy J
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144720071.98
222 rdf:type schema:Person
223 sg:person.01264377732.13 schema:affiliation grid-institutes:grid.38142.3c
224 schema:familyName Yock
225 schema:givenName Torunn I
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264377732.13
227 rdf:type schema:Person
228 sg:person.014651513125.83 schema:affiliation grid-institutes:grid.15444.30
229 schema:familyName Min
230 schema:givenName Chul Hee
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014651513125.83
232 rdf:type schema:Person
233 sg:person.016700357012.88 schema:affiliation grid-institutes:grid.38142.3c
234 schema:familyName Adams
235 schema:givenName Judith
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016700357012.88
237 rdf:type schema:Person
238 grid-institutes:grid.15444.30 schema:alternateName Department of Radiation Convergence Engineering, Yonsei University, Wonju, Korea
239 schema:name Department of Radiation Convergence Engineering, Yonsei University, Wonju, Korea
240 Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
241 rdf:type schema:Organization
242 grid-institutes:grid.38142.3c schema:alternateName Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
243 schema:name Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...